glp 1 breast feeding New GLP-1 Support Bundle Meet GSLIM: Safe GLP-1 Daily
Description
Billing complaints appear across Trustpilot, BBB, and ConsumerAffairs

Weight Loss: The average percent weight loss from patients starting weight after these 17 months at the maintenance dose was: -15% weight loss from baseline body weight at 68 weeks at the 2.4mg dose -In a two year follow up study, those who continued to take semaglutide at the 2.4mg dose were able to maintain an average of 15.2% of their initial weight

It reduces blood sugar levels, suppresses appetite, and delays stomach emptying
Key takeaways The FDA recently approved the first generic of Victoza (liraglutide injection) to improve glycemic control in patients 10 years and older with Type 2 diabetes, alongside diet and exercise

Some of this is driven by cost and access problems
Applying it topically while also taking it orally could theoretically compound effects in unpredictable ways, though absorption from patches is likely minimal
